| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.669 | 0.028 | 0.669 | Caspase 9 stimulant | |||
| 0.61 | 0.018 | 0.61 | Aldehyde oxidase inhibitor | |||
| 0.51 | 0.026 | 0.51 | 5 Hydroxytryptamine release stimulant | |||
| 0.489 | 0.03 | 0.489 | Vasodilator, peripheral | |||
| 0.46 | 0.006 | 0.46 | Alpha-N-acetylglucosaminidase inhibitor | 0.115 0.083 CID_91201566 | ||
| 0.487 | 0.037 | 0.487 | 5 Hydroxytryptamine release inhibitor | |||
| 0.477 | 0.036 | 0.507 | Cholesterol antagonist | 0.507 0.031 CID_91201566 | CID_91201566 | |
| 0.465 | 0.043 | 0.479 | Histamine release inhibitor | 0.479 0.037 CID_91201566 | CID_91201566 | |
| 0.419 | 0.004 | 0.419 | Alcohol dehydrogenase inhibitor | 0.112 0.041 CID_91201566 | ||
| 0.458 | 0.056 | 0.458 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.41 | 0.015 | 0.41 | Anesthetic general | |||
| 0.412 | 0.019 | 0.412 | Peroxidase inhibitor | 0.137 0.086 CID_91201566 | ||
| 0.419 | 0.081 | 0.419 | Cyclophilin D inhibitor | |||
| 0.408 | 0.076 | 0.408 | Calcium channel L-type activator | |||
| 0.33 | 0.006 | 0.33 | Carbonic anhydrase XV inhibitor | 0.184 0.021 CID_91201566 | ||
| 0.39 | 0.066 | 0.39 | GABA C receptor rho-3 antagonist | |||
| 0.389 | 0.068 | 0.395 | Immunosuppressant | 0.395 0.065 CID_91201566 | CID_91201566 | |
| 0.335 | 0.02 | 0.335 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.145 CID_91201566 | ||
| 0.34 | 0.039 | 0.677 | Superoxide dismutase inhibitor | 0.677 0.005 CID_91201566 | CID_91201566 | |
| 0.306 | 0.016 | 0.306 | Neurotrophic factor enhancer | |||
| 0.305 | 0.022 | 0.374 | Diuretic | 0.374 0.014 CID_91201566 | CID_91201566 | |
| 0.289 | 0.006 | 0.289 | Catenin beta inhibitor | |||
| 0.291 | 0.012 | 0.291 | Succinate dehydrogenase inhibitor | 0.183 0.064 CID_91201566 | ||
| 0.335 | 0.063 | 0.335 | Apoptosis antagonist | |||
| 0.305 | 0.04 | 0.305 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.262 | 0.005 | 0.262 | Photosensitizer | 0.156 0.028 CID_91201566 | ||
| 0.297 | 0.046 | 0.297 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.306 | 0.068 | 0.373 | Spasmolytic | 0.373 0.046 CID_91201566 | CID_91201566 | |
| 0.243 | 0.005 | 0.243 | HIV-1 integrase (Overall Integration) inhibitor | 0.162 0.021 CID_91201566 | ||
| 0.363 | 0.132 | 0.363 | Apoptosis agonist | |||
| 0.234 | 0.005 | 0.234 | Phenylalanine 4-hydroxylase inhibitor | 0.083 0.035 CID_91201566 | ||
| 0.243 | 0.014 | 0.243 | GABA C receptor agonist | |||
| 0.255 | 0.032 | 0.255 | Insulin sensitizer | 0.168 0.11 CID_91201566 | ||
| 0.229 | 0.008 | 0.347 | Triose-phosphate isomerase inhibitor | 0.347 0.004 CID_91201566 | CID_91201566 | |
| 0.241 | 0.02 | 0.241 | 5 Hydroxytryptamine 3E antagonist | 0.194 0.073 CID_91201566 | ||
| 0.273 | 0.054 | 0.273 | Gastrin inhibitor | |||
| 0.228 | 0.01 | 0.228 | Carbonic anhydrase VI inhibitor | 0.144 0.022 CID_91201566 | ||
| 0.221 | 0.009 | 0.221 | MAP3K9 inhibitor | |||
| 0.229 | 0.017 | 0.229 | Neurotrophic factor | |||
| 0.229 | 0.019 | 0.229 | DNA intercalator | |||
| 0.236 | 0.027 | 0.272 | Phospholipase A2 inhibitor | 0.272 0.018 CID_91201566 | CID_91201566 | |
| 0.22 | 0.016 | 0.22 | UDP-glucose 4-epimerase inhibitor | |||
| 0.219 | 0.018 | 0.219 | Ferrochelatase inhibitor | |||
| 0.22 | 0.02 | 0.22 | Cystathionine beta-synthase inhibitor | |||
| 0.258 | 0.061 | 0.258 | DNA synthesis inhibitor | |||
| 0.242 | 0.046 | 0.242 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.259 | 0.064 | 0.259 | Vasodilator | 0.214 0.094 CID_91201566 | ||
| 0.202 | 0.01 | 0.202 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.2 | 0.009 | 0.2 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.287 | 0.098 | 0.287 | Vasodilator, coronary | |||
| 0.242 | 0.055 | 0.303 | RNA-directed DNA polymerase inhibitor | 0.303 0.031 CID_91201566 | CID_91201566 | |
| 0.193 | 0.007 | 0.193 | Alcohol oxidase inhibitor | |||
| 0.21 | 0.025 | 0.21 | Arachidonic acid antagonist | 0.139 0.102 CID_91201566 | ||
| 0.195 | 0.011 | 0.195 | Sphingomyelinase inhibitor | |||
| 0.196 | 0.011 | 0.196 | Creatine kinase inhibitor | 0.101 0.058 CID_91201566 | ||
| 0.212 | 0.029 | 0.212 | ATPase inhibitor | |||
| 0.197 | 0.015 | 0.197 | Mediator release inhibitor | |||
| 0.186 | 0.005 | 0.186 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.196 | 0.016 | 0.196 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.188 | 0.011 | 0.188 | ABCA1 expression enhancer | |||
| 0.282 | 0.105 | 0.348 | Transcription factor NF kappa B inhibitor | 0.348 0.078 CID_91201566 | CID_91201566 | |
| 0.215 | 0.039 | 0.215 | Amylase inhibitor | |||
| 0.227 | 0.053 | 0.227 | Non-steroidal antiinflammatory agent | |||
| 0.262 | 0.092 | 0.262 | Lipoxygenase inhibitor | 0.209 0.131 CID_91201566 | ||
| 0.251 | 0.083 | 0.342 | Antioxidant | 0.342 0.048 CID_91201566 | CID_91201566 | |
| 0.28 | 0.113 | 0.28 | Calcium channel activator | |||
| 0.222 | 0.058 | 0.222 | Nitric-oxide synthase stimulant | |||
| 0.242 | 0.082 | 0.242 | Hypoglycemic | |||
| 0.172 | 0.012 | 0.172 | Ca2+-transporting ATPase inhibitor | |||
| 0.201 | 0.041 | 0.201 | Protein kinase stimulant | |||
| 0.268 | 0.112 | 0.52 | Antithrombotic | 0.52 0.026 CID_91201566 | CID_91201566 | |
| 0.173 | 0.019 | 0.173 | NMDA receptor antagonist | 0.162 0.021 CID_91201566 | ||
| 0.185 | 0.032 | 0.185 | Aldehyde dehydrogenase inhibitor | |||
| 0.174 | 0.021 | 0.272 | Catalase inhibitor | 0.272 0.007 CID_91201566 | CID_91201566 | |
| 0.184 | 0.031 | 0.184 | Toll-Like receptor 2 antagonist | |||
| 0.22 | 0.07 | 0.22 | Psychostimulant | |||
| 0.158 | 0.008 | 0.208 | Carbonic anhydrase VB inhibitor | 0.208 0.005 CID_91201566 | CID_91201566 | |
| 0.184 | 0.039 | 0.184 | GABA C receptor rho-2 antagonist | |||
| 0.169 | 0.023 | 0.169 | Mucolytic | |||
| 0.174 | 0.029 | 0.174 | MAP kinase kinase 4 inhibitor | |||
| 0.235 | 0.091 | 0.235 | Interleukin agonist | |||
| 0.174 | 0.031 | 0.174 | Adenylate cyclase stimulant | 0.168 0.038 CID_91201566 | ||
| 0.16 | 0.017 | 0.16 | DOPA decarboxylase inhibitor | |||
| 0.242 | 0.104 | 0.242 | Insulysin inhibitor | |||
| 0.162 | 0.024 | 0.162 | Potassium channel (Ca-activated) activator | |||
| 0.22 | 0.084 | 0.474 | Angiogenesis stimulant | 0.474 0.013 CID_91201566 | CID_91201566 | |
| 0.215 | 0.081 | 0.215 | Peptidyltransferase inhibitor | |||
| 0.151 | 0.018 | 0.151 | Phosphofructokinase-1 inhibitor | 0.062 0.055 CID_91201566 | ||
| 0.161 | 0.033 | 0.24 | Aminopeptidase B inhibitor | 0.24 0.014 CID_91201566 | CID_91201566 | |
| 0.224 | 0.097 | 0.224 | DNA damaging | |||
| 0.198 | 0.071 | 0.198 | Focal adhesion kinase 2 inhibitor | |||
| 0.23 | 0.105 | 0.307 | Immunostimulant | 0.307 0.076 CID_91201566 | CID_91201566 | |
| 0.141 | 0.017 | 0.186 | Carbonic anhydrase V inhibitor | 0.186 0.008 CID_91201566 | CID_91201566 | |
| 0.136 | 0.011 | 0.136 | Prostaglandin EP2 antagonist | |||
| 0.154 | 0.031 | 0.154 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.144 | 0.022 | 0.144 | Porphobilinogen synthase inhibitor | |||
| 0.142 | 0.02 | 0.142 | NADH dehydrogenase inhibitor | 0.085 0.066 CID_91201566 | ||
| 0.178 | 0.056 | 0.178 | Interleukin 6 antagonist | |||
| 0.146 | 0.025 | 0.146 | Estrogen antagonist | |||
| 0.209 | 0.088 | 0.209 | Hypolipemic | |||
| 0.148 | 0.027 | 0.148 | Adenylate kinase inhibitor | 0.101 0.066 CID_91201566 | ||
| 0.18 | 0.061 | 0.356 | Phospholipase C inhibitor | 0.356 0.014 CID_91201566 | CID_91201566 | |
| 0.149 | 0.031 | 0.149 | GABA C receptor antagonist | 0.125 0.048 CID_91201566 | ||
| 0.166 | 0.049 | 0.166 | Nav1.2 sodium channel blocker | 0.136 0.067 CID_91201566 | ||
| 0.166 | 0.049 | 0.166 | Cyclooxygenase 1 inhibitor | |||
| 0.154 | 0.037 | 0.154 | Heat shock protein 70 antagonist | |||
| 0.16 | 0.043 | 0.16 | Nav1.6 sodium channel blocker | |||
| 0.181 | 0.064 | 0.181 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.131 | 0.015 | 0.14 | Carbonic anhydrase VA inhibitor | 0.14 0.013 CID_91201566 | CID_91201566 | |
| 0.172 | 0.058 | 0.172 | Melanin inhibitor | |||
| 0.146 | 0.033 | 0.146 | Bronchodilator | |||
| 0.15 | 0.037 | 0.15 | 5-Lipoxygenase inhibitor | |||
| 0.17 | 0.058 | 0.17 | Hexokinase inhibitor | |||
| 0.172 | 0.06 | 0.172 | Neurotensin receptor agonist | |||
| 0.185 | 0.075 | 0.185 | P-glycoprotein inhibitor | |||
| 0.127 | 0.017 | 0.127 | Aminopeptidase I inhibitor | |||
| 0.136 | 0.028 | 0.136 | GABA C receptor rho-1 antagonist | |||
| 0.22 | 0.112 | 0.22 | Transcription factor STAT inhibitor | |||
| 0.126 | 0.019 | 0.126 | Glutamate decarboxylase inhibitor | |||
| 0.145 | 0.037 | 0.145 | Expectorant | |||
| 0.153 | 0.046 | 0.153 | Cyclooxygenase 3 inhibitor | |||
| 0.117 | 0.011 | 0.117 | Estrogen-related receptor beta agonist | |||
| 0.109 | 0.003 | 0.109 | GABA uptake inhibitor | |||
| 0.121 | 0.015 | 0.121 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.047 CID_91201566 | ||
| 0.132 | 0.026 | 0.132 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.241 | 0.138 | 0.241 | Sodium/bile acid cotransporter inhibitor | |||
| 0.217 | 0.114 | 0.217 | Transcription factor STAT3 inhibitor | |||
| 0.2 | 0.098 | 0.283 | Free radical scavenger | 0.283 0.056 CID_91201566 | CID_91201566 | |
| 0.226 | 0.123 | 0.226 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.159 | 0.057 | 0.159 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.127 | 0.026 | 0.127 | Estrogen receptor beta antagonist | |||
| 0.117 | 0.017 | 0.117 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.225 | 0.126 | 0.225 | 12-Lipoxygenase inhibitor | |||
| 0.145 | 0.047 | 0.149 | Cholesterol synthesis inhibitor | 0.149 0.045 CID_91201566 | CID_91201566 | |
| 0.119 | 0.02 | 0.119 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.104 | 0.008 | 0.104 | Aconitate hydratase inhibitor | |||
| 0.105 | 0.009 | 0.152 | Factor IXa inhibitor | 0.152 0.004 CID_91201566 | CID_91201566 | |
| 0.111 | 0.015 | 0.111 | Glycine receptor agonist | |||
| 0.161 | 0.065 | 0.161 | Interferon gamma antagonist | |||
| 0.123 | 0.028 | 0.123 | Histamine N-methyltransferase inhibitor | |||
| 0.1 | 0.005 | 0.1 | Sphingosine 1-phosphate receptor agonist | |||
| 0.162 | 0.068 | 0.411 | Protein-tyrosine phosphatase inhibitor | 0.411 0.008 CID_91201566 | CID_91201566 | |
| 0.11 | 0.016 | 0.11 | Biliverdin reductase inhibitor | |||
| 0.143 | 0.05 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.144 | 0.051 | 0.178 | Antibacterial (Helicobacter pylori) | 0.178 0.029 CID_91201566 | CID_91201566 | |
| 0.134 | 0.042 | 0.134 | Protein kinase C gamma inhibitor | |||
| 0.12 | 0.029 | 0.12 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.101 | 0.01 | 0.101 | Carbonic anhydrase XIV inhibitor | 0.045 0.039 CID_91201566 | ||
| 0.117 | 0.027 | 0.117 | Adrenaline agonist | |||
| 0.112 | 0.021 | 0.112 | Estrogen receptor alpha antagonist | |||
| 0.11 | 0.02 | 0.11 | Potassium channel large-conductance Ca-activated activator | |||
| 0.131 | 0.042 | 0.131 | Nav1.5 sodium channel blocker | 0.103 0.079 CID_91201566 | ||
| 0.114 | 0.026 | 0.143 | NMDA 2 receptor antagonist | 0.143 0.018 CID_91201566 | CID_91201566 | |
| 0.095 | 0.007 | 0.145 | Alpha-mannosidase inhibitor | 0.145 0.004 CID_91201566 | CID_91201566 | |
| 0.225 | 0.137 | 0.225 | Caspase 3 stimulant | |||
| 0.102 | 0.014 | 0.102 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.116 | 0.029 | 0.116 | Ornithine decarboxylase inhibitor | |||
| 0.102 | 0.016 | 0.102 | Beta adrenoreceptor antagonist | |||
| 0.153 | 0.067 | 0.153 | Cyclooxygenase inhibitor | |||
| 0.146 | 0.061 | 0.146 | Pregnane X receptor agonist | 0.145 0.062 CID_91201566 | ||
| 0.096 | 0.012 | 0.096 | Glutamate (mGluR6) antagonist | |||
| 0.135 | 0.052 | 0.226 | Protein-tyrosine phosphatase 1B inhibitor | 0.226 0.022 CID_91201566 | CID_91201566 | |
| 0.181 | 0.098 | 0.181 | Anticonvulsant | |||
| 0.255 | 0.173 | 0.511 | Antibacterial | 0.511 0.038 CID_91201566 | CID_91201566 | |
| 0.2 | 0.118 | 0.2 | Neuropeptide Y2 antagonist | |||
| 0.12 | 0.039 | 0.135 | Anabolic | 0.135 0.027 CID_91201566 | CID_91201566 | |
| 0.091 | 0.01 | 0.091 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.227 | 0.147 | 0.227 | Interleukin 2 agonist | |||
| 0.116 | 0.035 | 0.116 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.137 | 0.057 | 0.137 | DNA polymerase I inhibitor | |||
| 0.133 | 0.054 | 0.155 | Monophenol monooxygenase inhibitor | 0.155 0.045 CID_91201566 | CID_91201566 | |
| 0.085 | 0.006 | 0.085 | Liver X receptor alpha agonist | |||
| 0.106 | 0.027 | 0.106 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.086 | 0.008 | 0.141 | Mannosidase inhibitor | 0.141 0.004 CID_91201566 | CID_91201566 | |
| 0.089 | 0.011 | 0.089 | Glucosylceramidase inhibitor | |||
| 0.15 | 0.072 | 0.15 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.085 | 0.007 | 0.085 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.029 CID_91201566 | ||
| 0.148 | 0.071 | 0.148 | Thiol protease inhibitor | |||
| 0.082 | 0.005 | 0.082 | Melatonin agonist | |||
| 0.126 | 0.049 | 0.126 | Transcription factor STAT6 inhibitor | |||
| 0.106 | 0.029 | 0.106 | Myeloperoxidase inhibitor | |||
| 0.142 | 0.065 | 0.142 | Bone formation stimulant | |||
| 0.095 | 0.018 | 0.095 | MAP kinase kinase 7 inhibitor | |||
| 0.117 | 0.041 | 0.117 | Breast cancer-resistant protein inhibitor | |||
| 0.083 | 0.007 | 0.083 | Nicotinic acid receptor 2 agonist | |||
| 0.078 | 0.003 | 0.078 | Estrogen-related receptor beta antagonist | 0.031 0.026 CID_91201566 | ||
| 0.08 | 0.006 | 0.08 | Immunoglobulin Fc receptor antagonist | |||
| 0.103 | 0.029 | 0.103 | Keratolytic | |||
| 0.106 | 0.032 | 0.106 | Macrophage migration inhibitory factor inhibitor | |||
| 0.149 | 0.075 | 0.149 | Heat shock protein 90 antagonist | |||
| 0.085 | 0.011 | 0.085 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.082 | 0.009 | 0.082 | Lysophosphatidic acid 3 receptor antagonist | 0.054 0.03 CID_91201566 | ||
| 0.079 | 0.006 | 0.079 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.087 | 0.013 | 0.087 | Leukotriene B4 antagonist | 0.064 0.024 CID_91201566 | ||
| 0.089 | 0.016 | 0.089 | NMDA 2A receptor antagonist | |||
| 0.086 | 0.014 | 0.086 | MDM2 inhibitor | |||
| 0.096 | 0.024 | 0.096 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.105 | 0.033 | 0.105 | CYP2A6 inhibitor | |||
| 0.107 | 0.035 | 0.107 | Topoisomerase II alpha inhibitor | |||
| 0.114 | 0.042 | 0.114 | Prolactin inhibitor | |||
| 0.076 | 0.004 | 0.076 | Liver X receptor beta antagonist | |||
| 0.183 | 0.112 | 0.183 | Aryl hydrocarbon receptor agonist | |||
| 0.126 | 0.055 | 0.126 | Microtubule formation inhibitor | |||
| 0.113 | 0.042 | 0.113 | Uric acid excretion stimulant | |||
| 0.091 | 0.02 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | 0.082 0.025 CID_91201566 | ||
| 0.157 | 0.087 | 0.157 | Antipruritic | |||
| 0.085 | 0.014 | 0.085 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.042 CID_91201566 | ||
| 0.132 | 0.062 | 0.132 | Nav1.3 sodium channel blocker | |||
| 0.091 | 0.022 | 0.091 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.087 | 0.019 | 0.087 | Beta 3 adrenoreceptor antagonist | |||
| 0.128 | 0.06 | 0.128 | Proteasome inhibitor | |||
| 0.079 | 0.011 | 0.079 | Aldosterone antagonist | |||
| 0.083 | 0.015 | 0.083 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.085 | 0.017 | 0.085 | Thromboxane antagonist | |||
| 0.107 | 0.04 | 0.107 | Phosphodiesterase 6D inhibitor | 0.098 0.056 CID_91201566 | ||
| 0.145 | 0.078 | 0.145 | NOS3 expression enhancer | |||
| 0.103 | 0.038 | 0.103 | Glutamate release inhibitor | |||
| 0.09 | 0.025 | 0.09 | GABA B receptor agonist | |||
| 0.077 | 0.013 | 0.077 | Thromboxane synthase inhibitor | |||
| 0.069 | 0.005 | 0.069 | Complement C5a chemotactic receptor antagonist | |||
| 0.09 | 0.026 | 0.09 | Elastase 1 inhibitor | |||
| 0.121 | 0.058 | 0.121 | Caspase 3 inhibitor | |||
| 0.084 | 0.021 | 0.084 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.13 | 0.067 | 0.13 | Vanilloid 1 agonist | 0.114 0.104 CID_91201566 | ||
| 0.074 | 0.011 | 0.074 | Adenosine deaminase inhibitor | 0.068 0.014 CID_91201566 | ||
| 0.168 | 0.105 | 0.168 | Interleukin antagonist | |||
| 0.079 | 0.016 | 0.079 | Sphingosine kinase 2 inhibitor | |||
| 0.125 | 0.063 | 0.125 | Topoisomerase II inhibitor | |||
| 0.096 | 0.033 | 0.096 | Glutamate dehydrogenase inhibitor | |||
| 0.089 | 0.027 | 0.089 | Leukotriene antagonist | |||
| 0.095 | 0.034 | 0.095 | Histidine decarboxylase inhibitor | |||
| 0.08 | 0.018 | 0.08 | Beta 1 adrenoreceptor antagonist | |||
| 0.075 | 0.013 | 0.075 | Beta 2 adrenoreceptor agonist | 0.062 0.042 CID_91201566 | ||
| 0.068 | 0.006 | 0.068 | Melatonin 2 agonist | |||
| 0.187 | 0.126 | 0.187 | Calpain inhibitor | |||
| 0.105 | 0.044 | 0.105 | Calcium antagonist | |||
| 0.068 | 0.007 | 0.068 | Retinoic acid alpha receptor agonist | |||
| 0.143 | 0.082 | 0.143 | Acetylcholine M1 receptor antagonist | |||
| 0.077 | 0.017 | 0.077 | Thromboxane A2 antagonist | |||
| 0.077 | 0.018 | 0.077 | Calcium channel P-type blocker | |||
| 0.075 | 0.016 | 0.075 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.124 | 0.065 | 0.15 | Alkylator | 0.15 0.047 CID_91201566 | CID_91201566 | |
| 0.098 | 0.039 | 0.158 | Carbonic anhydrase XIII inhibitor | 0.158 0.02 CID_91201566 | CID_91201566 | |
| 0.111 | 0.052 | 0.111 | Xanthine oxidase inhibitor | |||
| 0.073 | 0.015 | 0.073 | Beta 2 adrenoreceptor antagonist | |||
| 0.073 | 0.015 | 0.073 | NMDA receptor subunit 3B antagonist | |||
| 0.095 | 0.038 | 0.095 | Cell adhesion molecule inhibitor | 0.082 0.05 CID_91201566 | ||
| 0.067 | 0.009 | 0.067 | Nicotinic acid receptor agonist | |||
| 0.11 | 0.053 | 0.11 | Carbonic anhydrase III inhibitor | 0.101 0.061 CID_91201566 | ||
| 0.062 | 0.005 | 0.062 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.088 | 0.032 | 0.088 | Calcium channel L-type blocker | |||
| 0.174 | 0.118 | 0.174 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.069 | 0.014 | 0.069 | NMDA receptor subunit 3A antagonist | |||
| 0.076 | 0.021 | 0.076 | Cyclin D1 inhibitor | |||
| 0.093 | 0.038 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 CID_91201566 | CID_91201566 | |
| 0.234 | 0.179 | 0.482 | 15-Lipoxygenase inhibitor | 0.482 0.045 CID_91201566 | CID_91201566 | |
| 0.064 | 0.009 | 0.064 | AMPA 4 receptor antagonist | |||
| 0.064 | 0.01 | 0.064 | Retinoid X alpha receptor agonist | |||
| 0.175 | 0.121 | 0.175 | Platelet antagonist | 0.149 0.146 CID_91201566 | ||
| 0.093 | 0.039 | 0.093 | D-Ala-D-Ala ligase inhibitor | |||
| 0.062 | 0.01 | 0.074 | Guanylate cyclase inhibitor | 0.074 0.004 CID_91201566 | CID_91201566 | |
| 0.107 | 0.055 | 0.107 | Factor V inhibitor | |||
| 0.078 | 0.026 | 0.078 | NMDA 2C receptor antagonist | 0.063 0.041 CID_91201566 | ||
| 0.058 | 0.006 | 0.058 | Free fatty acid receptor 1 antagonist | |||
| 0.073 | 0.022 | 0.073 | Sphingosine kinase inhibitor | 0.054 0.052 CID_91201566 | ||
| 0.123 | 0.072 | 0.123 | Cathepsin H inhibitor | |||
| 0.059 | 0.008 | 0.059 | Liver X receptor beta agonist | |||
| 0.101 | 0.051 | 0.101 | Interleukin 12 antagonist | |||
| 0.056 | 0.007 | 0.056 | Melatonin antagonist | |||
| 0.067 | 0.018 | 0.067 | Pregnane X receptor antagonist | |||
| 0.118 | 0.069 | 0.118 | Anesthetic local | |||
| 0.081 | 0.033 | 0.129 | Phospholipase D inhibitor | 0.129 0.005 CID_91201566 | CID_91201566 | |
| 0.055 | 0.006 | 0.055 | Melatonin receptor 1A agonist | |||
| 0.061 | 0.013 | 0.061 | Retinoid X receptor agonist | |||
| 0.073 | 0.026 | 0.073 | Phosphodiesterase 1C inhibitor | |||
| 0.107 | 0.06 | 0.107 | Beta glucuronidase inhibitor | |||
| 0.059 | 0.012 | 0.059 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.088 | 0.041 | 0.088 | Interferon agonist | 0.076 0.06 CID_91201566 | ||
| 0.066 | 0.019 | 0.066 | Leukotriene C antagonist | |||
| 0.06 | 0.014 | 0.06 | Thymidine kinase inhibitor | |||
| 0.117 | 0.07 | 0.117 | Acetylcholine muscarinic antagonist | |||
| 0.08 | 0.034 | 0.08 | Glucagon-like peptide 1 agonist | |||
| 0.091 | 0.046 | 0.091 | Glutathione S-transferase inhibitor | |||
| 0.059 | 0.014 | 0.059 | Cytokine production stimulant | |||
| 0.116 | 0.071 | 0.116 | Adenylate cyclase inhibitor | |||
| 0.101 | 0.056 | 0.101 | Electrolyte absorption antagonist | |||
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | |||
| 0.084 | 0.041 | 0.084 | GABA aminotransferase inhibitor | |||
| 0.054 | 0.011 | 0.054 | Glutamate (mGluR3) antagonist | |||
| 0.082 | 0.039 | 0.082 | Phosphodiesterase VI inhibitor | |||
| 0.066 | 0.024 | 0.066 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.052 | 0.009 | 0.052 | Prostaglandin EP3 antagonist | |||
| 0.118 | 0.076 | 0.118 | Cholinergic antagonist | |||
| 0.139 | 0.097 | 0.139 | CF transmembrane conductance regulator agonist | |||
| 0.054 | 0.012 | 0.054 | Angiotensin AT1 receptor antagonist | |||
| 0.049 | 0.007 | 0.052 | Ceramide glucosyltransferase inhibitor | 0.052 0.005 CID_91201566 | CID_91201566 | |
| 0.059 | 0.018 | 0.059 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.048 | 0.006 | 0.048 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.123 | 0.082 | 0.202 | Alkaline phosphatase inhibitor | 0.202 0.032 CID_91201566 | CID_91201566 | |
| 0.068 | 0.027 | 0.068 | Ornithine carbamoyltransferase inhibitor | |||
| 0.046 | 0.005 | 0.046 | Sodium/glucose cotransporter inhibitor | |||
| 0.072 | 0.032 | 0.072 | Interferon inducer | 0.065 0.042 CID_91201566 | ||
| 0.067 | 0.027 | 0.179 | Estrogen agonist | 0.179 0.009 CID_91201566 | CID_91201566 | |
| 0.098 | 0.059 | 0.098 | MAP kinase kinase 1 inhibitor | |||
| 0.046 | 0.007 | 0.046 | Prostaglandin EP2 agonist | |||
| 0.119 | 0.08 | 0.119 | Cyclooxygenase 2 inhibitor | |||
| 0.069 | 0.03 | 0.069 | Argininosuccinate synthase inhibitor | |||
| 0.07 | 0.032 | 0.07 | Purinergic P2X1 antagonist | |||
| 0.091 | 0.053 | 0.091 | ATPase (Vacuolar H+) inhibitor | |||
| 0.049 | 0.011 | 0.049 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.104 | 0.066 | 0.104 | Topoisomerase I inhibitor | |||
| 0.057 | 0.02 | 0.057 | Adenylate cyclase 1 inhibitor | |||
| 0.127 | 0.09 | 0.251 | Cell wall synthesis inhibitor | 0.251 0.016 CID_91201566 | CID_91201566 | |
| 0.096 | 0.059 | 0.132 | Bile acid receptor antagonist | 0.132 0.012 CID_91201566 | CID_91201566 | |
| 0.046 | 0.009 | 0.046 | Uridine phosphorylase inhibitor | |||
| 0.047 | 0.011 | 0.047 | Prostaglandin agonist | |||
| 0.049 | 0.013 | 0.049 | Prostacyclin antagonist | |||
| 0.061 | 0.025 | 0.061 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.04 | 0.005 | 0.04 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 CID_91201566 | ||
| 0.085 | 0.05 | 0.127 | Glycine receptor antagonist | 0.127 0.014 CID_91201566 | CID_91201566 | |
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | |||
| 0.047 | 0.012 | 0.047 | CF transmembrane conductance regulator antagonist | |||
| 0.059 | 0.025 | 0.059 | Prolyl endopeptidase inhibitor | |||
| 0.177 | 0.143 | 0.177 | Cardiotonic | |||
| 0.051 | 0.017 | 0.051 | Dopamine D5 agonist | |||
| 0.048 | 0.015 | 0.069 | Phosphoglycerate kinase inhibitor | 0.069 0.01 CID_91201566 | CID_91201566 | |
| 0.152 | 0.119 | 0.152 | MAP kinase kinase 2 inhibitor | |||
| 0.047 | 0.015 | 0.047 | Retinoid X receptor antagonist | |||
| 0.111 | 0.079 | 0.111 | Acetylcholine antagonist | |||
| 0.05 | 0.017 | 0.05 | Beta adrenoreceptor agonist | |||
| 0.099 | 0.067 | 0.106 | Gastric antisecretory | 0.106 0.059 CID_91201566 | CID_91201566 | |
| 0.057 | 0.024 | 0.057 | CD45 antagonist | |||
| 0.038 | 0.006 | 0.038 | Estrogen-related receptor gamma antagonist | |||
| 0.056 | 0.025 | 0.056 | Squalene epoxidase inhibitor | |||
| 0.048 | 0.016 | 0.048 | Diamine oxidase inhibitor | |||
| 0.037 | 0.006 | 0.037 | Melatonin 1 antagonist | |||
| 0.043 | 0.012 | 0.043 | AMPA 3 receptor antagonist | |||
| 0.043 | 0.012 | 0.043 | Angiotensin II receptor antagonist | |||
| 0.084 | 0.053 | 0.084 | Caspase 7 inhibitor | |||
| 0.076 | 0.045 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.045 | 0.015 | 0.045 | Sirtuin 2 inhibitor | |||
| 0.081 | 0.051 | 0.081 | Somatostatin 1 agonist | |||
| 0.034 | 0.004 | 0.034 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.058 | 0.029 | 0.058 | Sigma receptor antagonist | |||
| 0.065 | 0.035 | 0.065 | Acetylcholine M5 receptor antagonist | |||
| 0.039 | 0.01 | 0.039 | Liver X receptor alpha antagonist | |||
| 0.048 | 0.018 | 0.048 | Sphingosine kinase 1 inhibitor | |||
| 0.112 | 0.082 | 0.112 | MAP kinase kinase inhibitor | |||
| 0.043 | 0.013 | 0.043 | AMPA 2 receptor antagonist | |||
| 0.072 | 0.043 | 0.072 | Protein kinase C beta inhibitor | |||
| 0.064 | 0.036 | 0.064 | Androgen agonist | |||
| 0.059 | 0.03 | 0.059 | DNA helicase inhibitor | |||
| 0.046 | 0.018 | 0.046 | Kainate receptor 2 antagonist | |||
| 0.041 | 0.013 | 0.041 | Retinoid X alpha receptor antagonist | |||
| 0.033 | 0.005 | 0.033 | G-protein-coupled receptor 120 agonist | |||
| 0.035 | 0.007 | 0.035 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.047 | 0.019 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.06 | 0.032 | 0.06 | Prostaglandin antagonist | |||
| 0.05 | 0.023 | 0.05 | Geranyltranstransferase inhibitor | |||
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.044 | 0.017 | 0.044 | Leukotriene C4 antagonist | |||
| 0.035 | 0.009 | 0.035 | Prostaglandin H2 antagonist | |||
| 0.106 | 0.08 | 0.106 | Cell adhesion inhibitor | |||
| 0.041 | 0.015 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.12 | 0.094 | 0.12 | Lipid peroxidase inhibitor | |||
| 0.047 | 0.022 | 0.047 | Nerve growth factor antagonist | |||
| 0.069 | 0.044 | 0.069 | Glutamate (mGluR7) antagonist | |||
| 0.038 | 0.013 | 0.038 | Sigma 1 receptor antagonist | |||
| 0.046 | 0.021 | 0.046 | Plasmepsin II inhibitor | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.104 | 0.079 | 0.126 | Acetylcholine release stimulant | 0.126 0.039 CID_91201566 | CID_91201566 | |
| 0.08 | 0.057 | 0.08 | Histamine H1 receptor antagonist | |||
| 0.045 | 0.022 | 0.045 | Heme oxygenase inhibitor | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR8) agonist | |||
| 0.032 | 0.009 | 0.032 | Prostaglandin E2 agonist | |||
| 0.066 | 0.043 | 0.066 | CDC25B inhibitor | |||
| 0.038 | 0.015 | 0.038 | ATP citrate lysase inhibitor | |||
| 0.048 | 0.026 | 0.048 | Dihydroorotase inhibitor | |||
| 0.038 | 0.015 | 0.038 | Liver X receptor antagonist | |||
| 0.052 | 0.03 | 0.052 | AMPA receptor antagonist | |||
| 0.082 | 0.06 | 0.082 | T cell inhibitor | |||
| 0.064 | 0.042 | 0.064 | NMDA receptor glycine site agonist | |||
| 0.028 | 0.006 | 0.028 | Retinoic acid beta receptor agonist | |||
| 0.067 | 0.046 | 0.067 | Bcl2 antagonist | |||
| 0.038 | 0.017 | 0.038 | Melatonin 1 agonist | |||
| 0.034 | 0.013 | 0.034 | Prostaglandin EP4 antagonist | |||
| 0.055 | 0.035 | 0.055 | Aldose reductase inhibitor | |||
| 0.034 | 0.013 | 0.123 | NMDA 2D receptor antagonist | 0.123 0.004 CID_91201566 | CID_91201566 | |
| 0.053 | 0.033 | 0.053 | Prostaglandin E2 antagonist | |||
| 0.035 | 0.015 | 0.035 | Leukotriene B4 receptor 1 antagonist | |||
| 0.095 | 0.075 | 0.095 | Falcipain 3 inhibitor | |||
| 0.033 | 0.014 | 0.033 | Thiazolidinedione | |||
| 0.038 | 0.019 | 0.038 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.055 | 0.037 | 0.055 | Dihydroorotate oxidase inhibitor | |||
| 0.028 | 0.01 | 0.028 | Prostaglandin F2 alpha agonist | |||
| 0.024 | 0.007 | 0.024 | Follicle-stimulating hormone antagonist | 0.023 0.007 CID_91201566 | ||
| 0.03 | 0.012 | 0.03 | Thymidine phosphorylase inhibitor | |||
| 0.095 | 0.078 | 0.095 | AMP-activated protein kinase stimulant | |||
| 0.038 | 0.021 | 0.038 | Fumarate hydratase inhibitor | |||
| 0.023 | 0.007 | 0.023 | Antibiotic Anthracycline-like | |||
| 0.039 | 0.023 | 0.039 | Arginase inhibitor | |||
| 0.027 | 0.011 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.088 | 0.073 | 0.088 | MAO A inhibitor | |||
| 0.026 | 0.011 | 0.026 | Leukotriene B4 receptor 2 antagonist | |||
| 0.072 | 0.058 | 0.072 | Vanilloid 4 agonist | |||
| 0.033 | 0.018 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.058 | 0.044 | 0.058 | Acetylcholine M3 receptor antagonist | |||
| 0.047 | 0.032 | 0.049 | Phosphorylase inhibitor | 0.049 0.031 CID_91201566 | CID_91201566 | |
| 0.043 | 0.029 | 0.043 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.025 | 0.011 | 0.025 | Isoleucine-tRNA ligase inhibitor | |||
| 0.049 | 0.036 | 0.049 | Factor III inhibitor | |||
| 0.019 | 0.006 | 0.019 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.083 | 0.07 | 0.083 | Bromodomain-containing protein 2 inhibitor | |||
| 0.023 | 0.01 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.04 | 0.027 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.029 | 0.016 | 0.029 | Myristoyl transferase inhibitor | |||
| 0.05 | 0.037 | 0.054 | Dihydroorotate dehydrogenase inhibitor | 0.054 0.034 CID_91201566 | CID_91201566 | |
| 0.03 | 0.018 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.127 | 0.115 | 0.127 | Mcl-1 antagonist | |||
| 0.043 | 0.031 | 0.043 | Liver X receptor agonist | |||
| 0.048 | 0.037 | 0.048 | Potassium channel (Inward rectifier) blocker | |||
| 0.109 | 0.098 | 0.109 | DNA repair enzyme inhibitor | |||
| 0.079 | 0.068 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.051 CID_91201566 | CID_91201566 | |
| 0.055 | 0.044 | 0.055 | Dopamine uptake inhibitor | |||
| 0.032 | 0.022 | 0.032 | Glutamate (mGluR3) agonist | |||
| 0.023 | 0.012 | 0.023 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.028 | 0.018 | 0.028 | Hedgehog signaling activator | |||
| 0.058 | 0.048 | 0.058 | Bcl-xL inhibitor | |||
| 0.132 | 0.123 | 0.132 | Amyloid beta precursor protein antagonist | |||
| 0.043 | 0.033 | 0.043 | Glutamate (mGluR group III) antagonist | |||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.034 | 0.025 | 0.034 | RNA-directed RNA polymerase inhibitor | |||
| 0.078 | 0.069 | 0.078 | Thioredoxin reductase inhibitor | |||
| 0.027 | 0.018 | 0.027 | Sigma 2 receptor antagonist | |||
| 0.045 | 0.037 | 0.045 | Cholesterol esterase inhibitor | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.025 | 0.018 | 0.025 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.022 | 0.015 | 0.147 | Glutamate (mGluR1a) agonist | 0.147 0.003 CID_91201566 | CID_91201566 | |
| 0.051 | 0.043 | 0.08 | Heparanase inhibitor | 0.08 0.007 CID_91201566 | CID_91201566 | |
| 0.023 | 0.016 | 0.023 | ICAM 1 antagonist | |||
| 0.023 | 0.016 | 0.023 | Retinoic acid receptor agonist | |||
| 0.078 | 0.07 | 0.078 | Histamine H2 receptor antagonist | |||
| 0.024 | 0.017 | 0.122 | Glutamate (mGluR1) agonist | 0.122 0.003 CID_91201566 | CID_91201566 | |
| 0.02 | 0.014 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.043 | 0.037 | 0.043 | Thymidylate synthase inhibitor | |||
| 0.059 | 0.052 | 0.059 | Neutrophil collagenase inhibitor | |||
| 0.012 | 0.006 | 0.012 | Thromboxane agonist | |||
| 0.045 | 0.039 | 0.045 | Metalloproteinase-3 inhibitor | |||
| 0.022 | 0.016 | 0.022 | Geranylgeranyltransferase inhibitor | |||
| 0.053 | 0.046 | 0.053 | Aromatase inhibitor | |||
| 0.057 | 0.051 | 0.132 | NMDA receptor agonist | 0.132 0.011 CID_91201566 | CID_91201566 | |
| 0.013 | 0.007 | 0.013 | Melatonin 2 antagonist | |||
| 0.064 | 0.058 | 0.064 | Exportin-1 inhibitor | |||
| 0.041 | 0.035 | 0.041 | Glutamate (mGluR4) antagonist | |||
| 0.058 | 0.052 | 0.058 | Dopamine D1 antagonist | |||
| 0.017 | 0.011 | 0.017 | Vitamin D receptor agonist | |||
| 0.03 | 0.024 | 0.03 | Cholesterol ester transfer protein antagonist | |||
| 0.02 | 0.015 | 0.02 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.016 | 0.01 | 0.016 | Thromboxane A2 agonist | |||
| 0.059 | 0.055 | 0.059 | Aryl hydrocarbon receptor antagonist | |||
| 0.043 | 0.038 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.109 | 0.104 | 0.109 | Toll-Like receptor antagonist | |||
| 0.016 | 0.011 | 0.016 | Adenosine A2 receptor agonist | |||
| 0.127 | 0.123 | 0.127 | Nitric oxide antagonist | |||
| 0.019 | 0.015 | 0.019 | Retinoic acid alpha receptor antagonist | |||
| 0.015 | 0.01 | 0.015 | Prostaglandin EP4 agonist | |||
| 0.041 | 0.037 | 0.056 | Dihydrofolate reductase inhibitor | 0.056 0.013 CID_91201566 | CID_91201566 | |
| 0.055 | 0.05 | 0.165 | Carbonic anhydrase inhibitor | 0.165 0.014 CID_91201566 | CID_91201566 | |
| 0.089 | 0.085 | 0.089 | Glutamate (mGluR7) agonist | |||
| 0.052 | 0.048 | 0.052 | Fatty acid synthase inhibitor | |||
| 0.021 | 0.018 | 0.021 | Beta 1 adrenoreceptor agonist | |||
| 0.009 | 0.005 | 0.009 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.036 | 0.033 | 0.036 | 5 Hydroxytryptamine 2B agonist | |||
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.15 | 0.147 | 0.15 | Antiamyloidogenic | |||
| 0.097 | 0.094 | 0.097 | MAO inhibitor | |||
| 0.1 | 0.097 | 0.1 | Interleukin 8 antagonist | |||
| 0.056 | 0.053 | 0.056 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.028 | 0.025 | 0.028 | Prostaglandin D2 agonist | |||
| 0.057 | 0.054 | 0.057 | I kappa B kinase 2 inhibitor | |||
| 0.016 | 0.014 | 0.016 | Free fatty acid receptor 1 agonist | |||
| 0.131 | 0.129 | 0.131 | DNA methyltransferase I inhibitor | |||
| 0.032 | 0.03 | 0.032 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.017 | 0.015 | 0.017 | Retinoic acid receptor antagonist | |||
| 0.022 | 0.02 | 0.022 | Phosphodiesterase 6A inhibitor | |||
| 0.019 | 0.017 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.099 | 0.098 | 0.099 | Glutamate receptor antagonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.019 | 0.018 | 0.019 | Adenosine kinase inhibitor | |||
| 0.025 | 0.024 | 0.025 | AMPA 1 receptor antagonist | |||
| 0.021 | 0.02 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.046 | 0.048 | 0.08 | Carbonic anhydrase II inhibitor | 0.08 0.025 CID_91201566 | CID_91201566 | |
| 0.064 | 0.068 | 0.292 | CDC25A inhibitor | 0.292 0.004 CID_91201566 | CID_91201566 | |
| 0.044 | 0.048 | 0.105 | Carbonic anhydrase I inhibitor | 0.105 0.017 CID_91201566 | CID_91201566 | |
| 0.081 | 0.085 | 0.103 | Protein kinase C zeta inhibitor | 0.103 0.047 CID_91201566 | CID_91201566 | |
| 0.061 | 0.067 | 0.064 | HIV-1 integrase inhibitor | 0.064 0.058 CID_91201566 | CID_91201566 | |
| 0.022 | 0.03 | 0.024 | Complement factor 1s inhibitor | 0.024 0.023 CID_91201566 | CID_91201566 | |
| 0.043 | 0.06 | 0.137 | HIV-1 integrase (Strand Transfer) inhibitor | 0.137 0.014 CID_91201566 | CID_91201566 | |
| 0.176 | 0.193 | 0.194 | Immunomodulator | 0.194 0.172 CID_91201566 | CID_91201566 | |
| 0.037 | 0.054 | 0.083 | Carbonic anhydrase IX inhibitor | 0.083 0.026 CID_91201566 | CID_91201566 | |
| 0.057 | 0.076 | 0.119 | Cathepsin G inhibitor | 0.119 0.027 CID_91201566 | CID_91201566 | |
| 0.027 | 0.052 | 0.57 | Cholecystokinin B agonist | 0.57 0.002 CID_91201566 | CID_91201566 | |
| 0.025 | 0.051 | 0.034 | Carboxypeptidase B inhibitor | 0.034 0.021 CID_91201566 | CID_91201566 | |
| 0.045 | 0.076 | 0.125 | HIV-1 integrase (3'-Processing) inhibitor | 0.125 0.018 CID_91201566 | CID_91201566 | |
| 0.108 | 0.142 | 0.199 | Hemostatic | 0.199 0.033 CID_91201566 | CID_91201566 | |
| 0.021 | 0.056 | 0.055 | Farnesoid X receptor agonist | 0.055 0.012 CID_91201566 | CID_91201566 | |
| 0.015 | 0.076 | 0.027 | Trypsin II inhibitor | 0.027 0.025 CID_91201566 | CID_91201566 | |
| 0.016 | 0.087 | 0.034 | Factor VIIa inhibitor | 0.034 0.031 CID_91201566 | CID_91201566 | |
| 0.047 | 0.118 | 0.068 | Trypsin inhibitor | 0.068 0.035 CID_91201566 | CID_91201566 | |
| 0.023 | 0.097 | 0.1 | Leukocyte elastase inhibitor | 0.1 0.009 CID_91201566 | CID_91201566 | |
| 0.018 | 0.107 | 0.055 | Glutamate (mGluR group I) agonist | 0.055 0.026 CID_91201566 | CID_91201566 | |
| 0.023 | 0.117 | 0.05 | Glutamate (mGluR5) agonist | 0.05 0.026 CID_91201566 | CID_91201566 | |
| 0.05 | 0.15 | 0.096 | Chymotrypsin inhibitor | 0.096 0.039 CID_91201566 | CID_91201566 | |
| 0.071 | 0.173 | 0.177 | Thrombolytic | 0.177 0.064 CID_91201566 | CID_91201566 | |
| 0.038 | 0.142 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 CID_91201566 | CID_91201566 | |
| 0.09 | 0.197 | 0.131 | Platelet adhesion inhibitor | 0.131 0.129 CID_91201566 | CID_91201566 | |
| 0.064 | 0.172 | 0.126 | Nav1.4 sodium channel blocker | 0.126 0.047 CID_91201566 | CID_91201566 | |
| 0.205 | 0.326 | 0.341 | Antiinflammatory | 0.341 0.18 CID_91201566 | CID_91201566 | |
| 0.024 | 0.148 | 0.31 | Selectin antagonist | 0.31 0.005 CID_91201566 | CID_91201566 | |
| 0.075 | 0.201 | 0.567 | Anticoagulant | 0.567 0.007 CID_91201566 | CID_91201566 | |
| 0.017 | 0.143 | 0.052 | Purinergic P2Y2 antagonist | 0.052 0.01 CID_91201566 | CID_91201566 | |
| 0.011 | 0.14 | 0.079 | Factor Xa inhibitor | 0.079 0.018 CID_91201566 | CID_91201566 | |
| 0.011 | 0.145 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 CID_91201566 | CID_91201566 | |
| 0.006 | 0.144 | 0.281 | Cholecystokinin A agonist | 0.281 0.002 CID_91201566 | CID_91201566 | |
| 0.005 | 0.146 | 0.367 | Cholecystokinin agonist | 0.367 0.002 CID_91201566 | CID_91201566 | |
| 0.023 | 0.175 | 0.232 | NMDA 2B receptor antagonist | 0.232 0.005 CID_91201566 | CID_91201566 | |
| 0.004 | 0.169 | 0.077 | Estrone sulfatase inhibitor | 0.077 0.005 CID_91201566 | CID_91201566 | |
| 0.03 | 0.196 | 0.095 | Thrombin inhibitor | 0.095 0.029 CID_91201566 | CID_91201566 | |
| 0.005 | 0.181 | 0.191 | Cholecystokinin A antagonist | 0.191 0.005 CID_91201566 | CID_91201566 | |
| 0.006 | 0.189 | 0.117 | Cholecystokinin antagonist | 0.117 0.007 CID_91201566 | CID_91201566 | |
| 0.017 | 0.204 | 0.092 | Elastase inhibitor | 0.092 0.012 CID_91201566 | CID_91201566 | |
| 0.004 | 0.198 | 0.092 | Cholecystokinin B antagonist | 0.092 0.005 CID_91201566 | CID_91201566 | |
| 0.039 | 0.246 | 0.18 | Aminoacyl-tRNA synthetase inhibitor | 0.18 0.013 CID_91201566 | CID_91201566 | |
| 0.059 | 0.288 | 0.595 | Dual specificity phosphatase inhibitor | 0.595 0.005 CID_91201566 | CID_91201566 | |
| 0.05 | 0.303 | 0.602 | Dual specificity phosphatase 3 inhibitor | 0.602 0.004 CID_91201566 | CID_91201566 | |
| 0.013 | 0.292 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 CID_91201566 | CID_91201566 | |
| 0.054 | 0.475 | 0.557 | Angiogenesis inhibitor | 0.557 0.021 CID_91201566 | CID_91201566 | |
| 0.023 | 0.457 | 0.136 | Multidrug resistance-associated protein 1 inhibitor | 0.136 0.033 CID_91201566 | CID_91201566 | |
| 0.022 | 0.472 | 0.148 | Viral attachment inhibitor | 0.148 0.008 CID_91201566 | CID_91201566 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |